Shangcong Han

Prof. Dr. Shangcong Han

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
TLTian Liu
Tian Liu
SHShangcong Han
Shangcong Han
YYYu Yao
Yu Yao
GZGuiming Zhang
Guiming Zhang
In recent years, the abnormal glucose metabolism of tumor cells has attracted increasing attention. Abnormal glucose metabolism is closely related to the occurrence and development of tumors. Monocarboxylate transporters (MCTs) transport the sugar metabolites lactic acid and pyruvate, which affect glucose metabolism and tumor progression in a variety of ways. Thus, research has recently focused on MCTs and their potential functions in cancer. The MCT superfamily consists of 14 members. MCT1 and MCT4 play a crucial role in the maintenance of intracellular pH in tumor cells by transporting monocarboxylic acids (such as lactate, pyruvate and butyrate). MCT1 and MCT4 are highly expressed in a variety of tumor cells and are involved the proliferation, invasion and migration of tumor cells, which are closely related to the prognosis of cancer. Because of their important functions in tumor cells, MCT1 and MCT4 have become potential targets for cancer treatment. In this review, we focus on the structure, function and regulation of MCT1 and MCT4 and discuss the developed inhibitors of MCT1 and MCT4 to provide more comprehensive information that might aid in the development of strategies targeting MCTs in cancer.

1 February 2019 in Progress in Organic Coatings
Verified
Journal Article
Closed access
ZYZhanpeng Ye
Zhanpeng Ye
PZPengsheng Zhang
Pengsheng Zhang
Jianhua ZhangJianhua Zhang
Jianhua Zhang
LDLiandong Deng
Liandong Deng
JZJinwei Zhang
Jinwei Zhang
SHShangcong Han
Shangcong Han

1 February 2014 in Acta Biomaterialia
Verified
Journal Article
Closed access
SHShangcong Han
Shangcong Han
HWHaiying Wan
Haiying Wan
DLDaoshu Lin
Daoshu Lin
SGShutao Guo
Shutao Guo
HDHongxu Dong
Hongxu Dong
ADAnjie Dong
Anjie Dong

1 July 2021 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
HXHaoran Xia
Haoran Xia
YLYan Liang
Yan Liang
KCKeqi Chen
Keqi Chen
CGChunhua Guo
Chunhua Guo
MWMengdi Wang
Mengdi Wang
BHBin He
Bin He

1 December 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
XHXia Huang
Xia Huang
SHShangcong Han
Shangcong Han
ZCZuxian Chen
Zuxian Chen
LZLei Zhao
Lei Zhao
CWChangduo Wang
Changduo Wang
YSYong Sun
Yong Sun
Introduction: This study aimed to construct a layered double hydroxide (LDH) nanoparticle delivery system that was modified by deoxycholic acid (DCA) and hyaluronic acid (HA) to increase the bioavailability of oral insulin. Methods: LDH-DCA-HA was synthesized by the hybridization of DCA and HA with LDH. Subsequently, insulin was loaded onto LDH-DCA-HA, resulting in the formation of [email protected] The in vivo and in vitro mechanisms of insulin release, as well as the efficiency of insulin absorption, were analyzed before and after DCA-HA modification. Results: MTT assay showed that there was satisfactory biocompatibility between LDH-DCA-HA and Caco-2 cells at a concentration below 1000 μg/mL. Flow cytometry analysis revealed that Caco-2 cells absorbed [email protected] more readily than insulin. Measurement of transepithelial electrical resistance indicated that [email protected] induced the reversible opening of tight cell junctions, thereby facilitating its absorption. This was confirmed via laser confocal microscopy analysis, revealing that a large amount of zonula occludens-1 tight junction (TJ) protein was utilized for the paracellular pathway of nanoparticles. We also measured the blood glucose levels of type I diabetic mice and found that oral [email protected] exerted a steady hypoglycemic effect lasting 12 h, with a small range of postprandial blood glucose fluctuation. Immunofluorescence analysis showed that the strong penetration ability of [email protected] allowed insulin to enter epithelial cells more readily than free insulin. Finally, immunohistochemical analysis of anti-SLC10A1 protein confirmed that the cholic acid transporter receptor protein played a key role in the functioning of [email protected] Conclusion: LDH nanoparticles modified by DCA and HA improved the absorption efficiency of insulin by opening the TJs of cells and interacting with the cholic acid transporter receptor protein.

6 December 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
XZXianhu Zeng
Xianhu Zeng
YTYi Teng
Yi Teng
CZChunrong Zhu
Chunrong Zhu
ZLZhipeng Li
Zhipeng Li
TLTian Liu
Tian Liu
SHShangcong Han
Shangcong Han
Introduction: Sunitinib, a first-line therapy with a certain effect, was utilized in the early stages of renal cell carcinoma treatment. However, its clinical toxicity, side effects, and its limited bioavailability, resulted in inadequate clinical therapeutic efficacy. Building neoteric, simple, and safe drug delivery systems with existing drugs offers new options. Therefore, we aimed to construct a micelle to improve the clinical efficacy of sunitinib by reusing ibuprofen. Methods: We synthesized the sialic acid-poly (ethylene glycol)-ibuprofen (SA-PEG-IBU) amphipathic conjugate in two-step reaction. The SA-PEG-IBU amphiphilic conjugates can form into stable SPI nanomicelles in aqueous solution, which can be further loaded sunitinib (SU) to obtain the SPI/SU system. Following nanomicelle creation, sialic acid exposed to the nanomicelle surface can recognize the overexpressed E-selectin receptor on the membrane of cancer cells to enhance cellular uptake. The properties of morphology, stability, and drug release about the SPI/SU nanomicelles were investigated. Confocal microscopy and flow cytometry were used to assess the cellular uptake efficiency of nanomicelles in vitro. Finally, a xenograft tumor model in nude mice was constructed to investigate the body distribution and tumor suppression of SPI/SU in vivo. Results: The result showed that SPI nanomicelles exhibited excellent tumor targeting performance and inhibited the migration and invasion of tumor cell in vitro. The SPI nanomicelles can improve the accumulation of drugs in the tumor site that showed effective tumor inhibition in vivo. In addition, H&E staining and immunohistochemical analysis demonstrated that the SPI/SU nanomicelles had a superior therapeutic effect and lower biotoxicity. Conclusion: The SPI/SU nanomicelles displayed excellent anti-tumor ability, and can suppress the metastasis of tumor cell by decreasing the expression of Cyclooxygenase-2 due to the ibuprofen, providing an optimistic clinical application potential by developing a simple but safe drug delivery system.